Elsa Mauricio Reus

I joined SITU as the PART Trial Manager in November 2020. The PART Full Trial investigates whether partial treatment of the prostate using Vascular Targeted Photodynamic Therapy (VTP) is as effective in curing intermediate risk prostate cancer (and has fewer side effects) as radical treatments currently available on the NHS. I am also in charge of the PART Feasibility Trial, which preceded the PART Full Trial and it is currently on follow-up phase.

Prior to joining the Nuffield Department of Surgical Sciences, I worked as a Clinical Researcher on the Radcliffe Department of Medicine, coordinating a number of research studies and a Clinical Trial on the Division of Cardiovascular Medicine.

I graduated from the University Miguel Hernandez in Alicante in 2011 with a BSc in Pharmacy. A Masters in Clinical Research (MSc) from the University San Pablo-CEU in Madrid in 2014 and a Doctoral Degree in Human Movement from the University of Münster in Germany in 2018.